Findings reveal concurrent thyroid hormone irregularities and neurometabolic changes in the thalamic-cerebellum circuitry in MDD with ED, providing preliminary insights into the neurobiology of abnormal eating behaviors in depression.
Abstract
Objectives
The underlying mechanism of major depressive disorder (MDD) with eating disorder (ED) remains unclear. We aim to clarify the characteristic changes of THs and brain neurometabolic alterations in ED, and to explore their relationships.
Methods
The study included 28 individuals with MDD and ED, 81 individuals with MDD without ED, and 37 age-matched healthy controls (HCs). Serum TH levels were assessed, and 1H proton magnetic spectroscopy was utilized to determine the N-acetylaspartic acid to creatine (NAA/Cr) and choline-containing compounds to creatine ratios in the prefrontal cortex, anterior cingulate cortex, and thalamus. Subsequently, differential analysis, receiver operating characteristic (ROC) analysis, and correlation analysis were performed to explore their characteristics and interrelationships.
Results
In both MDD with ED and MDD without ED cohorts, free tri-iodothyronine (FT3) levels were significantly lower compared to HCs, whereas free thyroxine (FT4) and total thyroxine (TT4) levels were elevated. Significantly lower NAA/Cr ratios were observed in the right thalamus and higher NAA/Cr ratios in the left cerebellum in both MDD with ED and MDD without ED compared to HCs. Neurometabolic factors and THs levels achieved an ROC curve area of 0.830 in differentiating MDD with ED from MDD without ED. In addition, serum FT3 and TT4 levels showed a positive correlation with NAA/Cr in the eft cerebellum in cases of MDD with ED.
Conclusions
Our findings reveal concurrent thyroid hormone irregularities and neurometabolic changes in the thalamic-cerebellum circuitry in MDD with ED, providing preliminary insights into the neurobiology of abnormal eating behaviors in depression. Given the cross-sectional design, these results are exploratory and require validation. Level of evidence Level IV, cross-sectional study.
Whether thyroid-stimulating hormone levels, glycolipid metabolism parameters, and their associations with suicidal ideation (SI) in adolescents with MDD can serve as clinically useful biomarkers requires further validation in larger prospective studies.
Jun Li, Ying-Han Tian, Yu Zhuang et al.· Frontiers in Psychiatry· 0 citations
Preliminary findings highlight the need for further investigation into the neurobiological relevance of sleep disturbances in adolescent MDD, which may be associated with altered brain neurometabolism.
Yutong Liu, Qi-Lin Zhong, Liu Peng et al.· Journal of Affective Disorde...· 0 citations
Circulating lipid signaling molecules such as AEA and PEA may represent potential peripheral biomarkers of MDD, although longitudinal and mechanistic studies are needed to clarify the influence of treatment and comorbidities.
Muhammad Yaseen, Wei-Jen Chen, Jane-Pei-Chen Chang et al.· Brain, behavior, and immunit...· 1 citation
Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations, and MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk.
Yuhua Yang, Ningning Li, Li Zhou et al.· Molecular Psychiatry· 0 citations
The findings emphasise the importance of lipid metabolism and mitochondrial energy pathways in the pathophysiology of BD, while also highlighting the influence of mood state.
Talha Ağaç, M. Demirel, Fatmanur Köktaşoğlu et al.· Metabolic brain disease· 0 citations
Findings suggest a possible compensatory neurochemical pattern associated with low BMI in depression, however, the cross-sectional design cannot determine whether this pattern reflects compensatory adaptation or a pre-existing neurobiological subtype, and low BMI alone should not be interpreted as evidence of metabolic...
Shu-Shu Huang, Feng-Chun Wu, Liang-Da Zhong et al.· Journal of Affective Disorde...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.